These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 8749600)

  • 1. The effects of steroidal contraceptives on the well-being and sexuality of women: a double-blind, placebo-controlled, two-centre study of combined and progestogen-only methods.
    Graham CA; Ramos R; Bancroft J; Maglaya C; Farley TM
    Contraception; 1995 Dec; 52(6):363-9. PubMed ID: 8749600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 micrograms desogestrel and either 30 micrograms or 20 micrograms ethinyl oestradiol.
    Akerlund M; Røde A; Westergaard J
    Br J Obstet Gynaecol; 1993 Sep; 100(9):832-8. PubMed ID: 8218004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between mood and sexuality in women using an oral contraceptive as a treatment for premenstrual symptoms.
    Graham CA; Sherwin BB
    Psychoneuroendocrinology; 1993; 18(4):273-81. PubMed ID: 8316616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical experience with the progestogen-only pill.
    Broome M; Fotherby K
    Contraception; 1990 Nov; 42(5):489-95. PubMed ID: 2125544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects on ovarian activity of ulipristal acetate when 'quickstarting' a combined oral contraceptive pill: a prospective, randomized, double-blind parallel-arm, placebo-controlled study.
    Cameron ST; Berger C; Michie L; Klipping C; Gemzell-Danielsson K
    Hum Reprod; 2015 Jul; 30(7):1566-72. PubMed ID: 25994664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, double-blind study of two combined oral contraceptives containing the same progestogen, but different estrogens. World Health Organization Task Force on Oral Contraception.
    Contraception; 1980 May; 21(5):445-59. PubMed ID: 7428356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enlarged follicles in women using oral contraceptives.
    Broome M; Clayton J; Fotherby K
    Contraception; 1995 Jul; 52(1):13-6. PubMed ID: 8521709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of two triphasic oral contraceptives containing either gestodene or norethindrone: a randomized, controlled trial.
    Weber-Diehl F; Lehnert J; Lachnit U
    Contraception; 1993 Oct; 48(4):291-301. PubMed ID: 8222658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined oral contraceptive use is associated with both improvement and worsening of mood in the different phases of the treatment cycle-A double-blind, placebo-controlled randomized trial.
    Lundin C; Danielsson KG; Bixo M; Moby L; Bengtsdotter H; Jawad I; Marions L; Brynhildsen J; Malmborg A; Lindh I; Sundström Poromaa I
    Psychoneuroendocrinology; 2017 Feb; 76():135-143. PubMed ID: 27923181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 micrograms ethinylestradiol/75 micrograms gestodene and 30 micrograms ethinylestradiol/75 micrograms gestodene, with respect to efficacy, cycle control, and tolerance.
    Endrikat J; Müller U; Düsterberg B
    Contraception; 1997 Mar; 55(3):131-7. PubMed ID: 9115000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of oral contraceptive on liver function tests of women with schistosomiasis in the Philippines.
    Sy FS; Osteria TS; Opiniano V; Gler S
    Contraception; 1986 Sep; 34(3):283-94. PubMed ID: 3098499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, double-blind study of two combined and two progestogen-only oral contraceptives.
    Sheth A; Jain U; Sharma S; Adatia A; Patankar S; Andolsek L; Pretnar-Darovec A; Belsey MA; Hall PE; Parker RA; Ayeni S; Pinol A; Li Hoi Foo C
    Contraception; 1982 Mar; 25(3):243-52. PubMed ID: 6804162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral contraceptive use changes brain activity and mood in women with previous negative affect on the pill--a double-blinded, placebo-controlled randomized trial of a levonorgestrel-containing combined oral contraceptive.
    Gingnell M; Engman J; Frick A; Moby L; Wikström J; Fredrikson M; Sundström-Poromaa I
    Psychoneuroendocrinology; 2013 Jul; 38(7):1133-44. PubMed ID: 23219471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized double blind study of two oral contraceptives.
    Sanhueza H; Sivin I; Kumar S; Kessler M; Carrasco A; Yee J
    Contraception; 1979 Jul; 20(1):29-48. PubMed ID: 477315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical comparison of two low-dose oral contraceptives, Minulet and Mercilon, in women over 30 years of age.
    Kirkman RJ; Pedersen JH; Fioretti P; Roberts HE
    Contraception; 1994 Jan; 49(1):33-46. PubMed ID: 8137624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of Norinyl 1/35 versus Lo-Ovral in Ile-Ife Nigeria.
    Ayangade O; Akinyemi A
    Int J Gynaecol Obstet; 1989 Oct; 30(2):165-70. PubMed ID: 2572488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined estrogen-progestin oral contraceptives and female sexuality: an updated review.
    Krapf JM; Goldstein AT
    Sex Med Rev; 2024 Jun; 12(3):307-320. PubMed ID: 38515302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, double-blind, placebo-controlled comparison of the impact of low-dose and triphasic oral contraceptives on follicular development.
    Young RL; Snabes MC; Frank ML; Reilly M
    Am J Obstet Gynecol; 1992 Sep; 167(3):678-82. PubMed ID: 1530022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the October 1995 pill scare in Grampian.
    Flett G; Gurney E; McKessock L; Reid J
    Br J Fam Plann; 1998 Apr; 24(1):18-20. PubMed ID: 9719702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An investigation into the effect of tenidap sodium on the pharmacokinetics of a combined oral contraceptive.
    Coates PE; Mesure R
    Br J Clin Pharmacol; 1995; 39 Suppl 1(Suppl 1):47S-50S. PubMed ID: 7547095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.